Weekly Semaglutide Offers Long-Term Relief: Better Glycaemic Control and Less Insulin in Type 2 Diabetes, Study Finds Medha Baranwal2 May 2025 9:00 AM ISTItaly: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable addition to treatment...
Long-Acting GLP-1RAs Lower Cardiovascular, Kidney Risks and Mortality in Type 2 Diabetes, Meta-Analysis Finds Medha Baranwal8 April 2025 8:00 AM ISTUK: A systematic review and meta-analysis of randomized trials have highlighted the significant benefits of long-acting glucagon-like peptide-1...
Serum PCBs Linked to Increased Cardiovascular Risk in Type 2 Diabetes Patients: Study Finds Medha Baranwal4 Feb 2025 8:30 AM ISTChina: A recent study has highlighted a potential link between serum polychlorinated biphenyls (PCBs) and an elevated risk of cardiovascular disease...
Continuous Glucose Monitoring Improves Glycemic Control and Reduces Clinical Events in Type 1 and Type 2 Diabetes: Study Medha Baranwal6 Jan 2025 8:30 AM ISTUSA: Using continuous glucose monitoring (CGM) can significantly reduce mortality risk in individuals with type 1 and type 2 diabetes, according to...
Spirituality and religious practices might contribute to improvement of glycemic control Niveditha Subramani8 July 2023 9:00 AM ISTStudies on the health effects of religion/spirituality have linked it to reduced depression and anxiety, increased longevity, and other physical and...
COPD among diabetics associated with increased mortality from respiratory causes Niveditha Subramani21 Jun 2023 8:00 PM ISTType 2 Diabetes (T2D) is a metabolic disorder over time leads to persistent hyperglycemia that can be attributed to either defective insulin secretion...
